LEVOLEUCOVORIN CALCIUM
- Product NDC
- 70436-209
- 11-digit product format
- 704360209
- Labeler code
- 70436
- Product ID
- 70436-209_041b2b7e-33b8-a347-e063-6394a90acbc2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levoleucovorin injection
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Slate Run Pharmaceuticals
- Application
- ANDA217314
- Marketing category
- ANDA
- Marketing start
- 2023-08-01
- Substance
- LEVOLEUCOVORIN CALCIUM
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Folate Analog [EPC], Folic Acid [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LEVOLEUCOVORIN CALCIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOLEUCOVORIN CALCIUM | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 778XL6VBS8 |
| Rxcui | 1720765, 1720773 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70436-209-80 | LEVOLEUCOVORIN CALCIUM | 17.5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 17.5 | | 1 |
| 70436-209-80 | LEVOLEUCOVORIN CALCIUM | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70436-209 | LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN INJECTION) INJECTION, SOLUTION [SLATE RUN PHARMACEUTICALS] | 1 | Current NDC, 2 package rows | 20230830_124bc214-62f8-40f9-a227-a35e2d1ff2a0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70436-209-80 | 70436020980 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-209-80) / 17.5 mL in 1 VIAL, SINGLE-DOSE | 2023-08-01 | No | No | Current |